Dr Paul Lovelock
Manager, Occup Health & Safety
Infrastructure and Research Operations (Medicine)
+61 7 334 64762
0414 239 831
Journal Articles
Pettigrew, Christopher A., Wayte, Nicola, Wronski, Ania, Lovelock, Paul K., Spurdle, Amanda B. and Brown, Melissa A. (2008) Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants. Breast Cancer Research and Treatment, 110 2: 227-234. doi:10.1007/s10549-007-9714-5
Lovelock, Paul K., Spurdle, Amanda B., Mok, Myth T. S., Farrugia, Daniel J., Lakhani, Sunil R., Healey, Sue, Arnold, Stephen, Buchanan, Daniel, kConFab Investigators, Couch, Fergus J., Henderson, Berik R., Goldgar, David E., Tavtigian, Sean V., Chenevix-Trench, Georgia and Brown, Melissa A (2007) Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?. Breast Cancer Research, 9 6: R82: 1-13. doi:10.1186/bcr1826
Lovelock, Paul K., Wong, Ee Ming, Sprung, Carl N., Marsh, Anna, Hobson, Karen, French, Juliet D., Southey, Melissa, kConFab Investigators, Sculley, Tom, Pandeya, Nirmala, Brown, Melissa A., Chenevix-Trench, Georgia, Spurdle, Amanda B. and McKay, Michael J. (2007) Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability. Breast Cancer Research and Treatment, 104 3: 257-266. doi:10.1007/s10549-006-9415-5
Lovelock P. K., Healey, S., Au, W., Sum, E, Y. M., Tesoriero, A., Wong, E. M., Hinson, S., Brinkworth, R., Bekessy, A., Diez, O., Izatt, L., Solomon, E., Jenkins, M., Renard, H., Hopper, J., Waring, P., kConFab Investigators, Tavtigian, S. V., Goldgar, D., Lindeman, G J ., Visvader, J. E., Couch, F. J., Henderson, B. R., Southey, M., Chenevix-Trench, G., Spurdle, A. B. and Brown, M. A. (2006) Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. Journal of Medical Genetics, 43 1: 74-83. doi:10.1136/jmg.2005.033258
Chenevix-Trench, Georgia, Healey, Sue, Lakhani, Sunil, Waring, Paul, Cummings, Margaret, Brinkworth, Ross, Deffenbaugh, Amie M., Burbidge, Lynn Anne, Pruss, Dmitry, Judkins, Thad, Scholl, Tom, Bekessy, Anna, Marsh, Anna, Lovelock, Paul, Wong, Ming, Tesoriero, Andrea, Renard, Helene, Southey, Melissa, Hopper, John L., Yannoukakos, Koulis, Brown, Melissa, kConFab Investigators, Easton, Douglas, Tavtigian, Sean V., Goldgar, David and Spurdle, Amanda B. (2006) Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance. Cancer Research, 66 4: 2019-2027. doi:10.1158/0008-5472.CAN-05-3546
Lose, Felicity, Lovelock, Paul, Chenevix-Trench, Georgia, Mann, Graham J., Pupo, Gulietta M. and Spurdle, Amanda B. (2006) Variation in the RAD51 gene and familial breast cancer. Breast Cancer Research, 8 3: R26-1-R26-7. doi:10.1186/bcr1415
Pettigrew, Christopher, Wayte, Nicola, Lovelock, Paul K., Tavtigian, Sean V, Chenevix-Trench, Georgia, Spurdle, Amanda B. and Brown, Melissa A. (2005) Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms. Breast Cancer Research, 7 6: R929-R939. doi:10.1186/bcr1324
Good, David A., Busfield, Frances, Fletcher, Barbara H., Lovelock, Paul K., Duffy, David L., Kesting, Janine B., Andersen, John and Shaw, Joanne T. E. (2004) Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone, 35 1: 277-282. doi:10.1016/j.bone.2004.01.010
Busfield, Frances, Duffy, David L., Kesting, Janine B., Walker, Shelley M., Lovelock, Paul K., Good, David, Tate, Heather, Watego, Denise, Marczak, Maureen, Hayman, Noel and Shaw, Joanne T. E. (2002) A genomewide search for type 2 diabetes-susceptibility genes in indigenous Australians. American Journal of Human Genetics, 70 2: 349-357. doi:10.1086/338626
Tate, JR, Hoffmann, MM, Lovelock, PK, Kesting, JB and Shaw, JT (2001) Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian. Annals of Clinical Biochemistry, 38 Pt 1: 46-53. doi:10.1258/0004563011900272
Good, D, Busfield, F, Duffy, D, Lovelock, PK, Kesting, JB, Cameron, DP and Shaw, JTE (2001) Familial Paget's disease of bone: Nonlinkage to the PDB1 and PDB2 loci on chromosomes 6p and 18q in a large pedigree. Journal of Bone And Mineral Research, 16 1: 33-38. doi:10.1359/jbmr.2001.16.1.33
Shaw, J., Tate, J., Kesting, J., Marczak, M., Berholz, J. R., Lovelock, P. K., Purdie, D. M., Hickman, P. and Cameron, D, P. (1999) Apoliprotein E polymorphism in indigenous Australian subjects: allelic frequencies and relationship with dyslipidaemia. Medical Journal of Australia, 170 4: 161-164.
Delaney, Stephen J., Koopman, Peter, Lovelock, Paul K. and Wainwright, Brandon J. (1994) Alternative splicing of the first nucleotide binding fold of CFTR in mouse testes is associated with specific stages of spermatogenesis. Genomics, 20 3: 517-518. doi:10.1006/geno.1994.1214
Delaney, Stephen J., Rich, Devra P., Thomson, Scott A., Hargrave, Murray R., Lovelock, Paul K., Welsh, Michael J. and Wainwright, Brandon J. (1993) Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nature Genetics, 4 4: 426-430. doi:10.1038/ng0893-426
Conference Papers
Brown, M. A., Chenevix-Trench, G., Lovelock, P. K., Pettigrew, C., Spurdle, A. B., Tavtigian, S. and Wayte, N. J. (2005). Evolutionary conservation analysis may help identify functional exonic splice enhancer motifs in BRCA1 and BRCA2. In: Proceedings of the Familial Cancer 2005: Research and Practice. Familial Cancer 2005: Research and Practice, Couran Cove, Queensland, (). 30 August - 3 September, 2005.
Brown, M. A., Chenevix-Trench, G., French, J. D., Hobson, K., KConFab Investigators, Lovelock, P. K., Marsh, A., McKay, M., Pandeya, N., Sculley, T., Southey, M. C., Sprung, C. N., Spurdle, A. B. and Wong, E. M. (2005). Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell line phenotypic variability. In: Proceedings of the Familial Cancer 2005: Research and Practice. Familial Cancer 2005: Research and Practice, Couran Cove, (). 30 August - 3 September, 2005.